Bristol-Myers Squibb to Pay $19.5 Million for Alleged Improper Drug Marketing to Encourage Prescriptions to Children, Elderly
BOSTON - Resolving allegations that it improperly marketed an antipsychotic drug to children and elderly patients, Bristol-Myers Squibb Company (BMS) has agreed to pay a total of $19.5 million in a multistate settlement, including more than $400,000 to Massachusetts, Attorney General Maura Healey announced today.
- Date:December 8, 2016
- Agency:Massachusetts Attorney General
- State Enforcement Agencies